Cite
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2
MLA
Xiao-Yi Wang, et al. “LINC01133 Promotes Hepatocellular Carcinoma Progression by Sponging MiR-199a-5p and Activating Annexin A2.” Clinical and Translational Medicine, vol. 11, no. 5, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....21fa9d8fca6e43243bd74de8d7e88cf5&authtype=sso&custid=ns315887.
APA
Xiao-Yi Wang, Shao-Lai Zhou, Jia Li, Dan Yin, Zheng-Jun Zhou, Zhi-Qiang Hu, Jian Zhou, Rong-Qi Sun, Peng-Cheng Wang, Chu-Bin Luo, Hao-Yang Xin, & Jia Fan. (2021). LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2. Clinical and Translational Medicine, 11(5).
Chicago
Xiao-Yi Wang, Shao-Lai Zhou, Jia Li, Dan Yin, Zheng-Jun Zhou, Zhi-Qiang Hu, Jian Zhou, et al. 2021. “LINC01133 Promotes Hepatocellular Carcinoma Progression by Sponging MiR-199a-5p and Activating Annexin A2.” Clinical and Translational Medicine 11 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....21fa9d8fca6e43243bd74de8d7e88cf5&authtype=sso&custid=ns315887.